Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05652608 · ClinicalTrials.gov registry record
Stronger Together Psoriatic Arthritis Wellness Study
A clinical trial of Psoriatic Arthritis, sponsored by Global Healthy Living Foundation.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05652608 is a study of Psoriatic Arthritis that is actively recruiting participants, run by Global Healthy Living Foundation. The registered enrollment target is 100 participants, below the 851-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05652608, a study of Psoriatic Arthritis, is actively recruiting participants, sponsored by Global Healthy Living Foundation.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients diagnosed with psoriatic arthritis (PsA) confront decisions about how to treat their disease, interact with their health care providers, and modify lifestyle choices that may improve treatment outcomes. With sponsorship support from Janssen and in partnership with the Cleveland Clinic, this survey study will seek to understand and examine whether people living with PsA are interested in and motivated to participate in wellness activities. This cross-sectional observational survey study will help researchers and clinicians to better understand what some of the barriers and facilitators experienced by patients are when considering participation in guided online wellness activities. People that qualify for the study and complete a 10-minute survey will be invited to participate in Immune Strength, an online wellness program developed by the Cleveland Clinic. Immune Strength is a free 10-week program for creating better habits for a more resilient immune system. By following this program, participants will have the opportunity to learn about how to develop strategies and implement behavior changes for healthier immune functioning. Participants will be recruited by the Global Healthy Living Foundation (GHLF). GHLF is the parent organization of the CreakyJoints® (CJ) arthritis patient community and primary site for the PCORI-funded Arthritis Patient Partnership with Comparative Effectiveness Researchers (AR-PoWER) Patient Powered Research Network (PPRN), known as ArthritisPower®. ArthritisPower is a subset of CreakyJoints members who have expressed interest in participating in research and signed an informed consent form to participate in the PPRN and its associated research. Any individuals recruited from CreakyJoints or Facebook, who are not already members of ArthritisPower will be encouraged to join the ArthritisPower registry research app, but will not be required to do so in order to participate in the study.
Conditions Studied
Interventions
- BEHAVIORAL Immune Strength
Study Locations (1)
New York
- Global Healthy Living Foundation - Upper Nyack
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2026-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05652608
The ClinicalTrials.gov registry entry for NCT05652608 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 851-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (88% lower). The listed sponsor is Global Healthy Living Foundation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Psoriatic Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Immune Strength is the first listed.
NCT05652608 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05652608 about?
NCT05652608 is a clinical study titled "Stronger Together Psoriatic Arthritis Wellness Study". Patients diagnosed with psoriatic arthritis (PsA) confront decisions about how to treat their disease, interact with their health care providers, and modify lifestyle choices that may improve treatment outcomes. With sponsorship support from Janssen and in partnership with the Cleveland Clinic, this...
What is the current status of trial NCT05652608?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2022-03-01. Estimated completion is 2026-03-01.
What conditions does trial NCT05652608 study?
This clinical trial studies the following conditions: Psoriatic Arthritis.
What interventions are being tested in trial NCT05652608?
The interventions under investigation include: Immune Strength (BEHAVIORAL).
Who is sponsoring clinical trial NCT05652608?
This trial is sponsored by Global Healthy Living Foundation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05652608 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psoriatic Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
RECRUITING · Phase 1
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.